Dopamine β hydroxylase as a potential drug target to combat hypertension
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine β hydroxylase as a potential drug target to combat hypertension
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2020-07-14
DOI
10.1080/13543784.2020.1795830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renal Denervation for Treating Hypertension
- (2019) Michael A. Weber et al. JACC-Cardiovascular Interventions
- Renal Denervation Update From the International Sympathetic Nervous System Summit
- (2019) Márcio G. Kiuchi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NEW APPROACHES AND PERSPECTIVES FOR THE PHARMACOLOGICAL TREATMENT OF ARTERIAL HYPERTENSION
- (2018) CAMELIA CRISTINA DIACONU FARMACIA
- Cardiovascular disease models: A game changing paradigm in drug discovery and screening
- (2018) Houman Savoji et al. BIOMATERIALS
- Effects of zamicastat treatment in a genetic model of salt-sensitive hypertension and heart failure
- (2018) Bruno Igreja et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Clinical trial design and new therapies for pulmonary arterial hypertension
- (2018) Olivier Sitbon et al. EUROPEAN RESPIRATORY JOURNAL
- Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon
- (2017) Seong Hee Kang et al. Hepatology International
- Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014
- (2017) Gregory A. Roth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GRK2 Regulates α 2 -Adrenergic Receptor–Dependent Catecholamine Release in Human Adrenal Chromaffin Cells
- (2017) Alessandro Cannavo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship
- (2017) Toyanji Joseph Punchaichira et al. NEUROGENETICS
- Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors
- (2017) Ada Ledonne et al. Frontiers in Cellular Neuroscience
- Current Situation of Medication Adherence in Hypertension
- (2017) Bernard Vrijens et al. Frontiers in Pharmacology
- A new PAMPA model using an in-house brain lipid extract for screening the blood–brain barrier permeability of drug candidates
- (2016) Joana Bicker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects
- (2016) J Ø Nielsen et al. JOURNAL OF HUMAN HYPERTENSION
- The crystal structure of human dopamine -hydroxylase at 2.9 A resolution
- (2016) T. V. Vendelboe et al. Science Advances
- The Sympathetic Nervous System Alterations in Human Hypertension
- (2015) G. Grassi et al. CIRCULATION RESEARCH
- The Sympathetic Nervous System in Hypertension: Back to the Future?
- (2015) Murray Esler CURRENT HYPERTENSION REPORTS
- Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-ß-hydroxylase inhibitor
- (2015) Nuno Miguel Pires et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: Comparison with nepicastat
- (2015) Maria João Bonifácio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The D3 dopamine receptor: From structural interactions to function
- (2015) Chiara Fiorentini et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat
- (2015) Nuno Miguel Pires et al. HYPERTENSION RESEARCH
- Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder
- (2015) Richard De La Garza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Checks and balances on cholinergic signaling in brain and body function
- (2015) Hermona Soreq TRENDS IN NEUROSCIENCES
- Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat
- (2015) Ana I. Loureiro et al. XENOBIOTICA
- Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex
- (2015) Paola Devoto et al. Brain and Behavior
- Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation
- (2014) Paola Devoto et al. ADDICTION BIOLOGY
- The Dopamineβ-Hydroxylase Inhibitor, Nepicastat, Reduces Different Alcohol-Related Behaviors in Rats
- (2014) Giancarlo Colombo et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction
- (2014) AS Ersbøll et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Etamicastat, a new dopamine-ß-hydroxylase inhibitor, pharmacodynamics and metabolism in rat
- (2014) Ana I. Loureiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
- (2014) O. Sitbon et al. EUROPEAN RESPIRATORY JOURNAL
- Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat
- (2014) Bruno Igreja et al. HYPERTENSION RESEARCH
- A Controlled Trial of Renal Denervation for Resistant Hypertension
- (2014) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. BLOOD PRESSURE
- Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor
- (2013) Ana I. Loureiro et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Etamicastat, a Novel Dopamine β-Hydroxylase Inhibitor: Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Hypertension
- (2013) Luis Almeida et al. CLINICAL THERAPEUTICS
- Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects
- (2013) Teresa Nunes et al. Drugs in research & development
- Effect of Food on the Pharmacokinetic Profile of Etamicastat (BIA 5-453)
- (2013) Manuel Vaz-da-Silva et al. Drugs in research & development
- Disulfiram: An Old Therapeutic with New Applications
- (2012) Kelly Barth et al. CNS & Neurological Disorders-Drug Targets
- β2-Adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: Antagonism by vitamin D3 and curcumin
- (2012) Serene Xavier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Process Research for Multikilogram Production of Etamicastat: A Novel Dopamine β-Hydroxylase Inhibitor
- (2012) Alexandre Beliaev et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Chronic Inhibition of Dopamine β-Hydroxylase Facilitates Behavioral Responses to Cocaine in Mice
- (2012) Meriem Gaval-Cruz et al. PLoS One
- Neural control of the circulation
- (2011) Gail D. Thomas ADVANCES IN PHYSIOLOGY EDUCATION
- Pharmacokinetics and Tolerability of Etamicastat Following Single and Repeated Administration in Elderly Versus Young Healthy Male Subjects: An Open-Label, Single-Center, Parallel-Group Study
- (2011) Teresa Nunes et al. CLINICAL THERAPEUTICS
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- Software and resources for computational medicinal chemistry
- (2011) Chenzhong Liao et al. Future Medicinal Chemistry
- Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring
- (2011) Alejandro de la Sierra et al. HYPERTENSION
- Single-Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5-453), a New Dopamine β-Hydroxylase Inhibitor, in Healthy Subjects
- (2011) José Francisco Rocha et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension
- (2011) John D. Bisognano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Structural Insight of Dopamine β-Hydroxylase, a Drug Target for Complex Traits, and Functional Significance of Exonic Single Nucleotide Polymorphisms
- (2011) Abhijeet Kapoor et al. PLoS One
- Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex
- (2011) Paola Devoto et al. PSYCHOPHARMACOLOGY
- Ligand-directed signalling at β-adrenoceptors
- (2010) Bronwyn A. Evans et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antihypertensive class matters for combination therapy
- (2010) William B. White Nature Reviews Cardiology
- Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure
- (2009) Yuqing Chen et al. JOURNAL OF HYPERTENSION
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
- (2009) Henry Krum et al. LANCET
- Sympathetic Neural Mechanisms in Human Cardiovascular Health and Disease
- (2009) Nisha Charkoudian et al. MAYO CLINIC PROCEEDINGS
- Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome
- (2008) Frank Ulrich et al. LIVER TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started